Defymed
PrivateCompany Overview
Defymed is a biotechnology company that develops and markets implantable bio-artificial medical devices for the physiological delivery of therapeutic compounds, with an initial focus on treating type 1 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
medical devicebio-artificial pancreascell encapsulationimplantable devicetype 1 diabetesdrug deliverycell therapyimplantable pancreasbio-artificial organdiabetes techbiotechmedtechglucose regulationmacro-encapsulationregenerative medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Defymed Comparables
Compare Defymed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Betalin Therapeutics | 84% | |
| Encellin | 81% | |
| Sernova Biotherapeutics Inc. | 81% | |
Defymed Funding Rounds
Historical fundraising activity
Defymed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Defymed's valuation, stock price, and market status.
See something wrong or outdated?